Ryaltris
-
Hikma launches RYALTRIS seasonal allergic rhinitis nasal spray in US
RYALTRIS is the only fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular in…
Read More » -
Glenmark receives marketing approval for Ryaltris in 13 countries
Raltris will be marketed in the rest of Europe by the Menarini Group as part of its exclusive licensing agreement…
Read More » -
Glenmark Pharma to launch nasal spray Ryaltris in EU
Ryaltris is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis in adults and children over 12 years of…
Read More » -
Glenmark inks pact with Menarini Group
The company will commercialise nasal spray Ryaltris across 33 countries in Europe, including the Balkan region Glenmark Pharmaceuticals said its…
Read More »